Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data.
Despite an increase in the use of targeted anticancer drugs and immunotherapy, cytotoxic anticancer drugs such as docetaxel continue to play a clinically important role. The aim of this study was to evaluate drug-drug interactions between docetaxel and coadministered medicines in patients with breas...
Main Authors: | Kwang-Hee Shin, Young-Mi Ah, Sang Hun Cha, Hye Duck Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0287382 |
Similar Items
-
Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data
by: HyeYeong Lee, et al.
Published: (2021-05-01) -
Blockchain-Based Processing of Health Insurance Claims for Prescription Drugs
by: Aysha Alnuaimi, et al.
Published: (2022-01-01) -
Comparing the Sensitivities of Measures of Adherence to Antihypertensive Drugs Using Korean National Health Insurance Claims Data
by: Choo E, et al.
Published: (2021-08-01) -
Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis
by: Hong Y. Choi, et al.
Published: (2021-05-01) -
US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
by: Jonathan G. Tardos, et al.
Published: (2021-03-01)